Understanding the Role of Doulas in Supporting People With PMADs
Key facts
- Who runs it
- University of Montana
- Where
- Missoula, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 75 people, planned
- Started
- 26 Nov 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Standard Doula Care Plus PMAD Intervention
- Standard Doula Care
- Record updated
- 14 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Participants must be over the age of 18
- Currently pregnant and between 13 and 26 gestational weeks at the time of enrollment
- Live in a HRSA-designated rural area of Montana
Who cannot take part
- They are under the age of 18
- Not currently pregnant
- Not between 13-26 gestational weeks at the time of enrollment
- If they do not live in a HRSA-designated rural are of Montana
This trial is currently available in United States.
- University of MontanaMissoula, United StatesContact: Jessica L Liddell, PhDTaking people
About the trial
What the trial wants to find out
Detailed Description The doula-led intervention developed during the first phase of this project will be pilot tested for feasibility. Following the recruitment procedures described in the recruitment and retention plan, approximately 75 participants will be enrolled into the study. Twenty-five of the participants will receive regular doula care and 25 of the participants will receive care from a doula trained in the PMAD doula training throughout their pregnancy, childbirth, and postpartum time period, following the intervention procedures developed in Aim 2 of this study. Twenty-five women will not receive care from a doula and will receive perinatal care as usual. Women in all groups will take surveys via REDCap during their enrollment in the intervention, at 1 month postpartum, 3 months, and 6 months postpartum (at the conclusion of the intervention). All participants who receive the PMAD doula intervention will complete checklists after each session with their doula, to assess fidelity to the intervention. Participant communication with their doula via patient notebook will also be assessed for fidelity to the intervention.
The 3 groups in the trial
- Standard Doula Care Plus the PMAD InterventionTreatment being tested
Participants in this arm will receive standard perinatal doula care provided by doulas trained in the DONA International doula training in addition to PMAD-specific care from their doulas.
Treatment: Standard Doula Care Plus PMAD Intervention
- Standard Doula CareExisting treatment, for comparison
Participants in this arm will receive standard perinatal doula care provided by doulas trained in the DONA International doula training.
- Standard Maternal CareNo study treatment, for comparison
In this arm participants will receive standard perinatal medical care and will not receive care from a doula.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 14 August 2026